
Oncologist

No OPD information available
Breast Cancer
Maternal Hyperphenylalaninemia
Acute Pain
Adult Soft Tissue Sarcoma
Amenorrhea
Autosomal Recessive Hypotrichosis
BRCA Positive Breast Cancer
Diarrhea
Gastrointestinal Stromal Tumor
HER-2 Positive Breast Cancer
Mastectomy
Melanoma
Menopause
Neurotoxicity Syndromes
Ovarian Cancer
Peripheral Neuropathy
Phenylketonuria (PKU)
Premature Ovarian Failure
Vulvar Cancer
Frances M. Boyle helps people with different health problems like breast cancer, acute pain, and other conditions. She is skilled in treating various diseases, including ovarian cancer and melanoma. Frances M. Boyle is also good at communicating with patients, making them feel comfortable and cared for.
Patients trust Frances M. Boyle because she listens to their concerns and explains things clearly. She stays updated on the latest medical knowledge and research to provide the best care possible. Frances M. Boyle works well with other medical professionals, collaborating to ensure patients receive comprehensive treatment.
Frances M. Boyle's work has positively impacted many patients' lives. She has helped people with breast cancer, ovarian cancer, and other conditions improve their health and well-being. Her research on high-risk phenotypes in ovarian cancer has contributed to the medical field's understanding of the disease.
One of Frances M. Boyle's notable publications is a study on age and ethnicity as high-risk factors in mucinous ovarian cancer. She has also been involved in clinical trials for treating metastatic breast cancer. Her dedication to research and patient care shows her commitment to improving healthcare outcomes.
In summary, Frances M. Boyle is a compassionate and skilled healthcare provider who goes above and beyond to help her patients. Through her expertise, communication skills, and commitment to staying updated on medical advancements, she has made a significant impact on the lives of those she treats.
Enrollment Status: Approved for marketing
Published: December 16, 2024
Intervention Type: Drug
Study Drug:
Study Phase:
